Stocks · Health care · Pharmaceutical Preparations

CytomX Therapeutics, Inc.

CTMX Clue Score46
United States Fiscal year ends December CIK 0001501989
2.57
+4.05%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
2.57 on 9 Oct 2026
7 5 2 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $3.40 14 Oct 2025 $3.42 15 Oct 2025 $3.41 16 Oct 2025 $3.28 17 Oct 2025 $3.20 20 Oct 2025 $3.74 21 Oct 2025 $3.62 22 Oct 2025 $3.39 23 Oct 2025 $3.30 24 Oct 2025 $3.26 27 Oct 2025 $3.36 28 Oct 2025 $3.32 29 Oct 2025 $3.26 30 Oct 2025 $3.33 31 Oct 2025 $3.57 3 Nov 2025 $3.93 4 Nov 2025 $4.09 5 Nov 2025 $4.21 6 Nov 2025 $4.19 7 Nov 2025 $3.62 10 Nov 2025 $4.19 11 Nov 2025 $4.10 12 Nov 2025 $4.23 13 Nov 2025 $3.86 14 Nov 2025 $3.88 17 Nov 2025 $3.55 18 Nov 2025 $3.66 19 Nov 2025 $3.63 20 Nov 2025 $3.77 21 Nov 2025 $3.88 24 Nov 2025 $3.97 25 Nov 2025 $4.15 26 Nov 2025 $4.22 28 Nov 2025 $4.28 1 Dec 2025 $4.29 2 Dec 2025 $3.81 3 Dec 2025 $4.00 4 Dec 2025 $4.08 5 Dec 2025 $3.95 8 Dec 2025 $3.87 9 Dec 2025 $3.89 10 Dec 2025 $3.90 11 Dec 2025 $4.06 12 Dec 2025 $4.19 15 Dec 2025 $4.13 16 Dec 2025 $4.25 17 Dec 2025 $4.11 18 Dec 2025 $3.88 19 Dec 2025 $4.00 22 Dec 2025 $4.12 23 Dec 2025 $4.20 24 Dec 2025 $4.40 26 Dec 2025 $4.39 29 Dec 2025 $4.19 30 Dec 2025 $4.16 31 Dec 2025 $4.26 2 Jan 2026 $4.25 5 Jan 2026 $4.12 6 Jan 2026 $4.14 7 Jan 2026 $4.30 8 Jan 2026 $4.26 9 Jan 2026 $4.35 12 Jan 2026 $4.34 13 Jan 2026 $4.09 14 Jan 2026 $4.30 15 Jan 2026 $4.25 16 Jan 2026 $5.39 20 Jan 2026 $5.37 21 Jan 2026 $5.29 22 Jan 2026 $5.72 23 Jan 2026 $5.54 26 Jan 2026 $5.34 27 Jan 2026 $5.93 28 Jan 2026 $5.90 29 Jan 2026 $5.74 30 Jan 2026 $5.69 2 Feb 2026 $6.09 3 Feb 2026 $6.07 4 Feb 2026 $5.67 5 Feb 2026 $5.24 6 Feb 2026 $5.67 9 Feb 2026 $5.70 10 Feb 2026 $5.53 11 Feb 2026 $5.56 12 Feb 2026 $5.43 13 Feb 2026 $5.32 17 Feb 2026 $5.27 18 Feb 2026 $5.41 19 Feb 2026 $5.47 20 Feb 2026 $5.43 23 Feb 2026 $5.58 24 Feb 2026 $5.44 25 Feb 2026 $5.78 26 Feb 2026 $5.48 27 Feb 2026 $5.37 2 Mar 2026 $5.34 3 Mar 2026 $4.81 4 Mar 2026 $5.07 5 Mar 2026 $4.77 6 Mar 2026 $4.68 9 Mar 2026 $5.03 10 Mar 2026 $4.88 11 Mar 2026 $4.88 12 Mar 2026 $4.87 13 Mar 2026 $4.68 16 Mar 2026 $6.75 17 Mar 2026 $5.45 18 Mar 2026 $4.40 19 Mar 2026 $4.78 20 Mar 2026 $4.45 23 Mar 2026 $4.46 24 Mar 2026 $4.24 25 Mar 2026 $4.22 26 Mar 2026 $4.42 27 Mar 2026 $4.52 30 Mar 2026 $4.41 31 Mar 2026 $4.70 1 Apr 2026 $4.56 2 Apr 2026 $4.56 6 Apr 2026 $4.40 7 Apr 2026 $4.30 8 Apr 2026 $4.25 9 Apr 2026 $4.24 10 Apr 2026 $4.39 13 Apr 2026 $4.39 14 Apr 2026 $4.54 15 Apr 2026 $4.56 16 Apr 2026 $4.89 17 Apr 2026 $4.82 20 Apr 2026 $4.89 21 Apr 2026 $4.76 22 Apr 2026 $4.61 23 Apr 2026 $4.45 24 Apr 2026 $4.40 27 Apr 2026 $4.29 28 Apr 2026 $4.12 29 Apr 2026 $4.05 30 Apr 2026 $4.22 1 May 2026 $4.18 4 May 2026 $4.18 5 May 2026 $4.08 6 May 2026 $4.13 7 May 2026 $4.00 8 May 2026 $3.98 11 May 2026 $3.86 12 May 2026 $3.88 13 May 2026 $3.79 14 May 2026 $3.78 15 May 2026 $3.61 18 May 2026 $3.50 19 May 2026 $3.64 20 May 2026 $3.72 21 May 2026 $3.76 22 May 2026 $3.76 26 May 2026 $3.69 27 May 2026 $3.81 28 May 2026 $3.71 29 May 2026 $3.60 1 Jun 2026 $3.45 2 Jun 2026 $3.16 3 Jun 2026 $3.22 4 Jun 2026 $3.18 5 Jun 2026 $3.00 8 Jun 2026 $2.94 9 Jun 2026 $2.98 10 Jun 2026 $2.91 11 Jun 2026 $2.98 12 Jun 2026 $3.01 15 Jun 2026 $3.04 16 Jun 2026 $2.93 17 Jun 2026 $2.96 18 Jun 2026 $2.95 22 Jun 2026 $3.04 23 Jun 2026 $3.15 24 Jun 2026 $3.32 25 Jun 2026 $3.27 26 Jun 2026 $3.40 29 Jun 2026 $3.74 30 Jun 2026 $3.75 1 Jul 2026 $3.60 2 Jul 2026 $3.82 6 Jul 2026 $3.81 7 Jul 2026 $3.84 8 Jul 2026 $3.83 9 Jul 2026 $3.96 10 Jul 2026 $3.76 13 Jul 2026 $3.70 14 Jul 2026 $3.66 15 Jul 2026 $3.68 16 Jul 2026 $3.67 17 Jul 2026 $3.62 20 Jul 2026 $3.52 21 Jul 2026 $3.42 22 Jul 2026 $3.33 23 Jul 2026 $3.33 24 Jul 2026 $3.24 27 Jul 2026 $3.25 28 Jul 2026 $3.22 29 Jul 2026 $3.17 30 Jul 2026 $3.28 31 Jul 2026 $3.10 3 Aug 2026 $3.17 4 Aug 2026 $3.32 5 Aug 2026 $3.35 6 Aug 2026 $3.37 7 Aug 2026 $3.46 10 Aug 2026 $3.44 11 Aug 2026 $3.45 12 Aug 2026 $3.49 13 Aug 2026 $3.35 14 Aug 2026 $3.36 17 Aug 2026 $3.45 18 Aug 2026 $3.39 19 Aug 2026 $3.57 20 Aug 2026 $3.29 21 Aug 2026 $3.28 24 Aug 2026 $3.29 25 Aug 2026 $3.37 26 Aug 2026 $3.32 27 Aug 2026 $3.42 28 Aug 2026 $3.21 31 Aug 2026 $3.36 1 Sep 2026 $3.67 2 Sep 2026 $3.72 3 Sep 2026 $3.68 4 Sep 2026 $3.71 8 Sep 2026 $3.65 9 Sep 2026 $3.54 10 Sep 2026 $3.35 11 Sep 2026 $3.29 14 Sep 2026 $3.20 15 Sep 2026 $2.69 16 Sep 2026 $2.77 17 Sep 2026 $2.82 18 Sep 2026 $2.76 21 Sep 2026 $2.76 22 Sep 2026 $2.94 23 Sep 2026 $2.78 24 Sep 2026 $2.75 25 Sep 2026 $2.70 28 Sep 2026 $2.69 29 Sep 2026 $2.75 30 Sep 2026 $2.72 1 Oct 2026 $2.63 2 Oct 2026 $2.56 5 Oct 2026 $2.58 6 Oct 2026 $2.56 7 Oct 2026 $2.55 8 Oct 2026 $2.47 9 Oct 2026 $2.57 McCarthy Sean A. CEO Sold on a plan $461.91K 6 Nov 2025 · at $4.54 · 9.3% of stake Ogden Christopher Chief Financial Officer Sold at will $124.11K 17 Mar 2026 · at $6.42 · 6.1% of stake Chu Yu-Waye Chief Medical Officer Sold at will $136.68K 17 Mar 2026 · at $6.42 · 10.1% of stake BELVIN MARCIA SVP, Chief Scientific Officer Sold at will $202.27K 17 Mar 2026 · at $6.42 · 9.5% of stake McCarthy Sean A. CEO Sold on a plan $764.14K 17 Mar 2026 · at $6.42 · 9.9% of stake Ogden Christopher Chief Financial Officer Sold at will $4.95K 15 Jun 2026 · at $3.05 · 0.5% of stake
0 buys4 sales at will2 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$76.20M
Net income
$17.37M
Free cash flow
$75.81M
Operating margin
-29.4%
Net margin
-22.8%
Return on equity
-17.5%
Return on capital
-17.8%
Revenue growth, 1 yr
-44.8%
Revenue growth, 5 yr
2.2% a year

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
68M -65M FY20 Fiscal year 2020 Revenue $68.43M Net income $64.82M Margin -94.7% 37M -116M FY21 Fiscal year 2021 Revenue $37.31M Net income $115.87M Margin -310.5% · growth -45.5% 53M -99M FY22 Fiscal year 2022 Revenue $53.16M Net income $99.32M Margin -186.8% · growth +42.5% 101M -569K FY23 Fiscal year 2023 Revenue $101.21M Net income $569.00K Margin -0.6% · growth +90.4% 138M 32M FY24 Fiscal year 2024 Revenue $138.10M Net income $31.87M Margin 23.1% · growth +36.4% 76M -17M FY25 Fiscal year 2025 Revenue $76.20M Net income $17.37M Margin -22.8% · growth -44.8%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
15 Jun 2026 Ogden Christopher
Chief Financial Officer
Sold at will $4.95K 0.5%
17 Mar 2026 McCarthy Sean A.
CEO
Sold on a plan $764.14K 9.9%
17 Mar 2026 BELVIN MARCIA
SVP, Chief Scientific Officer
Sold at will $202.27K 9.5%
17 Mar 2026 Chu Yu-Waye
Chief Medical Officer
Sold at will $136.68K 10.1%
17 Mar 2026 Ogden Christopher
Chief Financial Officer
Sold at will $124.11K 6.1%
6 Nov 2025 McCarthy Sean A.
CEO
Sold on a plan $461.91K 9.3%